Company Info

Number of Employees

220

Visit Website

Frontida BioPharm, Inc.

CDMO

Tagline

“Quality manufacturing, extraordinary care”

Overview

Frontida BioPharm is a CDMO launched by founding management team members of Frontage Laboratories. Frontida offers the capability to manufacture Highly Potent Active Ingredient products, Combination Products, as well as DEA schedules II – V products. The company’s Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps. Its AdaptDose™ technology platform can eliminate the need to reformulate after Phase I and reduces technical hurdles in the development and scale up processes. The company specialties include GMP commercial manufacture of oral solid dosages, oral liquids & suspensions, Mini-tablets, fixed dosage combinations and solvent granulations & coating. While Frontage and Frontida remain affiliates, they are separate business entities.

Company Services

Services/CapabilitiesCDMO

+ Development Services

Analytical Development & Validation
Bioanalytical Services
Process Development & Validation
Scale Up/Tech Transfer

+ Drug Product Manufacturing

Cytotoxic / High Potency Compounds (OEL < 1µg/m3)

+ Drug Substance Manufacturing

Controlled Substances

+ Packaging

Carton Packaging

Contributors

Ron Connolly